Lakeland Industries (NASDAQ:LAKE) CEO James Jenkins Buys 1,127 Shares of Stock

Lakeland Industries, Inc. (NASDAQ:LAKE) CEO James Jenkins bought 1,127 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The stock was acquired at an average cost of $8.88 per share, with a total value of $10,007.76. Following the transaction, the chief executive officer owned 94,565 shares of the company’s stock, valued at $839,737.20. This represents a 1.21% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Lakeland Industries Trading Up 3.6%

Shares of NASDAQ:LAKE opened at $9.17 on Tuesday. The company’s 50-day moving average price is $12.87 and its two-hundred day moving average price is $14.11. Lakeland Industries, Inc. has a one year low of $7.77 and a one year high of $27.28. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.83 and a quick ratio of 1.48. The stock has a market capitalization of $89.96 million, a PE ratio of -2.09 and a beta of 1.29.

Lakeland Industries (NASDAQ:LAKE) last released its earnings results on Wednesday, September 21st. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter. Lakeland Industries had a negative return on equity of 7.80% and a negative net margin of 19.41%.The business had revenue of $27.47 million for the quarter. On average, equities analysts forecast that Lakeland Industries, Inc. will post 0.48 EPS for the current fiscal year.

Lakeland Industries Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 24th. Stockholders of record on Monday, November 17th were issued a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Monday, November 17th. Lakeland Industries’s dividend payout ratio is presently -2.73%.

Analyst Ratings Changes

LAKE has been the topic of a number of recent analyst reports. Zacks Research downgraded shares of Lakeland Industries from a “hold” rating to a “strong sell” rating in a report on Tuesday, December 16th. Roth Capital decreased their price objective on shares of Lakeland Industries from $27.00 to $19.00 and set a “buy” rating for the company in a research report on Wednesday, December 10th. UBS Group set a $14.00 target price on shares of Lakeland Industries in a report on Wednesday, December 10th. Lake Street Capital cut their target price on shares of Lakeland Industries from $26.00 to $19.00 and set a “buy” rating for the company in a research note on Wednesday, December 10th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Lakeland Industries in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Lakeland Industries presently has an average rating of “Hold” and a consensus target price of $16.50.

Institutional Trading of Lakeland Industries

A number of hedge funds have recently modified their holdings of LAKE. First Eagle Investment Management LLC increased its position in Lakeland Industries by 27.3% during the 2nd quarter. First Eagle Investment Management LLC now owns 278,756 shares of the medical instruments supplier’s stock worth $3,794,000 after buying an additional 59,803 shares during the period. North Star Investment Management Corp. boosted its position in shares of Lakeland Industries by 22.9% in the second quarter. North Star Investment Management Corp. now owns 157,475 shares of the medical instruments supplier’s stock valued at $2,143,000 after acquiring an additional 29,292 shares during the period. Delta Investment Management LLC grew its stake in shares of Lakeland Industries by 8.6% in the second quarter. Delta Investment Management LLC now owns 36,317 shares of the medical instruments supplier’s stock valued at $494,000 after acquiring an additional 2,863 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Lakeland Industries by 42.3% during the first quarter. Goldman Sachs Group Inc. now owns 44,435 shares of the medical instruments supplier’s stock worth $902,000 after acquiring an additional 13,219 shares during the period. Finally, D.A. Davidson & CO. raised its stake in Lakeland Industries by 5.6% in the 2nd quarter. D.A. Davidson & CO. now owns 45,673 shares of the medical instruments supplier’s stock worth $622,000 after purchasing an additional 2,426 shares in the last quarter. Institutional investors and hedge funds own 71.69% of the company’s stock.

Lakeland Industries Company Profile

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.